Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/222842
Title: Unmet needs in hereditary angioedema: an international survey of physicians
Author: Buttgereit, Thomas
Aulenbacher, Felix
Adatia, Adil
Vera Ayala, Carolina
Ali Al-nesf, Maryam
Altrichter, Sabine
Abuzakouk, Mohamed
Al-ahmad, Mona
Mohammed Ali, Ramzy
Berardi, Alejandro
Boccon-gibod, Isabelle
Bouillet, Laurence
Brussino, Luisa
Barešić, Marko
J. Busse, Paula
D. Betschel, Stephen
Chong-neto, Herberto
Calderón Llosa, Oscar
J. Craig, Timothy
D. Dorr, Anthony
Duarte Dortas Junior, Sérgio
Fomina, Daria
Farkas, Henriette
Shen Fok, Jie
S. Grumach, Anete
Greve, Jens
Guilarte, Mar
Gonçalo, Margarida
Grivcheva-panovska, Vesna
Hide, Michihiro
Hakl, Roman
Jindal, Ankur
H. Katelaris, Constance
Kamaleswaran, Shailajah
Kinaciyan, Tamar
Latysheva, Elena
Ignacio Larco Sousa, José
Lleonart Bellfill, Ramón
Mobayed, Hassan
Metz, Martin
Nasr, Iman
T. Mitrevska, Natasa
Nicola, Stefania
Alberto Salvador Parisi, Claudio
Porebski, Grzegorz
Peter, Jonny
Paes Leme Ferriani, Mariana
Rosario Filho, Nelson
Enis Şekerel, Bülent
Sarquis Serpa, Faradiba
Stobiecki, Marcin
Trainotti, Susanne
Valerieva, Anna
Wongsa, Chamard
C. Y. Wong, Jane
Yucel, Esra
Li, Yinglei
Nenci, Chiara
Maurer, Marcus
Magerl, Markus
H. Li, Philip
Issue Date: 28-Jul-2025
Publisher: Springer Science and Business Media LLC
Abstract: BackgroundHereditary angioedema (HAE) is a rare and potentially life-threatening genetic disorder characterized by unpredictable attacks of angioedema. MENTALIST (UnMEt Needs in herediTAry angioedema-a gLobal physIcian perSpecTive) is the first international survey uncovering unmet needs and identifying barriers to optimal management in HAE following the latest update of the World Allergy Organization (WAO)/European Academy of Allergy and Clinical Immunology (EAACI) HAE guidelines.MethodsThis web-based survey comprised 24 questions on HAE management and unmet needs. HAE-expert physicians from the Angioedema Centers of Reference and Excellence network ranked unmet needs according to their own perspectives and their patients' perspectives, using a 10-point Likert scale ranging from 0 (not a challenge/unmet need at all) to 10 (huge challenge/unmet need).ResultsOf 64 respondents from 32 countries, most (91%) had > 5 years of experience in managing HAE. Overall, 48% of respondents (n = 31/64) reported that < 50% of their patients had achieved the WAO/EAACI HAE treatment goals of total disease control and normalization of life at the time of the survey. Implementation of consensus recommendations was found to be inconsistent across regions. Gaps in non-HAE-expert physician knowledge, treatment costs, and reimbursement for long-term prophylaxis were the highest-priority challenges according to the respondents. Burden of disease remains a challenge among patients, as reported by their physicians.ConclusionsThe MENTALIST findings highlight a need for removal of barriers to HAE treatment goals and propose a call to action to improve access to treatments, for greater provision of education for physicians and patients, critical collaboration with patient organizations and industry stakeholders and ultimately to optimize HAE care.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s13023-025-03739-8
It is part of: Orphanet Journal of Rare Diseases, 2025, vol. 20, issue. 1
URI: https://hdl.handle.net/2445/222842
Related resource: https://doi.org/10.1186/s13023-025-03739-8
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
s13023-025-03739-8.pdf1.19 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.